XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
Total
Common Stock
Additional Paid-in Capital
Retained Earnings
Beginning balance (in shares) at Mar. 31, 2021   6,805,294    
Beginning balances at Mar. 31, 2021 $ 404,927,441   $ 255,590,674 $ 149,336,767
Increase (Decrease) in Shareholders' Equity [Roll Forward]        
Proceeds from exercise of stock options (in shares)   111,122    
Proceeds from exercise of stock options 8,682,578   8,682,578  
Common stock repurchases (in shares)   (195,436)    
Common stock repurchases (31,112,523)     (31,112,523)
Restricted common stock expense under stock option plan, net of cancellations (in shares)   3,160    
Restricted common stock expense under stock option plan, net of cancellations 6,445,948   6,445,948  
Stock option expense 1,852,977   1,852,977  
Net (loss) income 28,210,920     28,210,920
Ending balance (in shares) at Sep. 30, 2021   6,724,140    
Ending balances at Sep. 30, 2021 419,007,341   272,572,177 146,435,164
Beginning balance (in shares) at Jun. 30, 2021   6,693,703    
Beginning balances at Jun. 30, 2021 405,470,862   261,446,129 144,024,733
Increase (Decrease) in Shareholders' Equity [Roll Forward]        
Proceeds from exercise of stock options (in shares)   87,628    
Proceeds from exercise of stock options 6,873,724   6,873,724  
Common stock repurchases (in shares)   (61,187)    
Common stock repurchases (10,029,661)     (10,029,661)
Restricted common stock expense under stock option plan, net of cancellations (in shares)   3,996    
Restricted common stock expense under stock option plan, net of cancellations 3,342,974   3,342,974  
Stock option expense 909,350   909,350  
Net (loss) income 12,440,092     12,440,092
Ending balance (in shares) at Sep. 30, 2021   6,724,140    
Ending balances at Sep. 30, 2021 $ 419,007,341   272,572,177 146,435,164
Beginning balance (in shares) at Mar. 31, 2022 6,348,314 6,348,314    
Beginning balances at Mar. 31, 2022 $ 373,024,428   280,907,085 92,117,343
Increase (Decrease) in Shareholders' Equity [Roll Forward]        
Proceeds from exercise of stock options (in shares)   4,300    
Proceeds from exercise of stock options 403,547   403,547  
Common stock repurchases (in shares)   (73,643)    
Common stock repurchases (14,314,088)     (14,314,088)
Restricted common stock expense under stock option plan, net of cancellations (in shares)   2,750    
Restricted common stock expense under stock option plan, net of cancellations 6,191,877   6,191,877  
Stock option expense 1,444,759   1,444,759  
Net (loss) income $ (10,168,857)     (10,168,857)
Ending balance (in shares) at Sep. 30, 2022 6,281,721 6,281,721    
Ending balances at Sep. 30, 2022 $ 356,581,666   288,947,268 67,634,398
Beginning balance (in shares) at Jun. 30, 2022   6,280,721    
Beginning balances at Jun. 30, 2022 354,127,052   285,126,690 69,000,362
Increase (Decrease) in Shareholders' Equity [Roll Forward]        
Restricted common stock expense under stock option plan, net of cancellations (in shares)   1,000    
Restricted common stock expense under stock option plan, net of cancellations 3,143,874   3,143,874  
Stock option expense 676,704   676,704  
Net (loss) income $ (1,365,964)     (1,365,964)
Ending balance (in shares) at Sep. 30, 2022 6,281,721 6,281,721    
Ending balances at Sep. 30, 2022 $ 356,581,666   $ 288,947,268 $ 67,634,398